Calibr - Drug Discovery at Scripps Research: In The Front Row at Scripps Research

7/20/2019; 58 minutes

Scientists at Calibr, the drug discovery division of Scripps Research, are advancing new medicines to treat cancer, degenerative diseases and chronic illnesses that affect children and the aging population. Three lead Calibr scientists will talk about some of the most promising drug candidates in the pipeline for treating unmet medical needs. Recorded on 06/13/2019. (#34807)

Related Programs

Translational Research and Technology Transfer


Subscribe to receive email notifications about featured videos.
(c)2019 Regents of the University of California. All right reserved. Terms and Conditions of Use.